Nutrien (NTR) Misses Q3 EPS by $1.59; Lowers Outlook

Nutrien (NYSE: NTR) reported Q3 EPS of $2.51, $1.59 worse than the analyst estimate of $4.10. Revenue for the quarter came in at $8.19 billion versus the consensus estimate of $8.97 billion.

GUIDANCE:

Nutrien sees FY2022 EPS of $13.25-$14.50, versus the consensus of $16.55.

For earnings history and earnings-related data on Nutrien (NTR) click here.

You May Also Be Interested In

• AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• MDA Space agrees to buy 70% stake in CLS for ~€567 million